Skip to main content
logo
Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.190
+0.070 (1.70%)
At close: May 29, 2026, 4:00 PM EDT
4.323
+0.133 (3.17%)
After-hours: May 29, 2026, 5:43 PM EDT

Cytek Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
5416498391,1921,3822,183
Market Cap Growth
56.49%-22.58%-29.66%-13.74%-36.68%-
Enterprise Value
306.36402.22569.29940.841,0561,819
Last Close Price
4.195.056.499.1210.2116.32
PE Ratio
----510.50-
Forward PE
254.2389.5626.14-44.39152.95
PS Ratio
2.653.224.186.188.4317.06
PB Ratio
1.651.902.123.033.255.39
P/TBV Ratio
1.641.892.143.143.333.29
P/FCF Ratio
--38.371883.29-8205.99
P/OCF Ratio
--33.04225.74-471.45
EV/Sales Ratio
1.502.002.844.876.4414.21
EV/EBITDA Ratio
----273.87174.87
EV/EBIT Ratio
-----198.59
EV/FCF Ratio
--26.051486.31-6836.54
Debt / Equity Ratio
0.040.040.020.030.030
Debt / EBITDA Ratio
----3.78-
Debt / FCF Ratio
--0.3917.58--
Net Debt / Equity Ratio
-0.76-0.72-0.68-0.64-0.77-0.90
Net Debt / EBITDA Ratio
7.778.6926.8413.50-84.71-35.06
Net Debt / FCF Ratio
30.5228.16-12.32-396.9714.86-1370.74
Asset Turnover
0.450.420.400.380.330.37
Inventory Turnover
--2.941.531.571.77
Quick Ratio
3.884.165.005.667.9511.89
Current Ratio
4.695.045.866.979.2613.01
Return on Equity (ROE)
-22.11%-18.05%-1.53%-2.97%0.60%1.04%
Return on Assets (ROA)
-19.84%-18.74%-4.36%-4.25%-0.72%1.37%
Return on Invested Capital (ROIC)
-54.65%-49.36%-10.74%-11.92%-3.06%7.58%
Return on Capital Employed (ROCE)
-11.67%-9.90%-4.72%-6.13%-0.40%2.94%
Earnings Yield
----0.20%0.00%
FCF Yield
--2.61%0.05%-0.01%
Buyback Yield / Dilution
1.64%2.19%3.45%2.37%-69.93%-150.13%
Total Shareholder Return
1.64%2.19%3.45%2.37%-69.93%-150.13%
SEC Filings: 10-K · 10-Q